Trial ID
22087
Sponsor ID
H3B-8800-G000-101
“An Open-label, Multicenter Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia (H3B-8800-G000-101)”
Principal Investigator
Mitul Gandhi, MD
1 Location
Locations
Fairfax Office
Learn More About This Trial
Other Relevant Trials
Trial ID
21328
Sponsor ID
KCP-8602-801
“A PHASE 1/2 OPEN-LABEL STUDY OF THE SAFETY, TOLERABILITY AND EFFICACY OF THE SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) COMPOUND ELTANEXOR (KPT-8602) IN PATIENTS WITH NEWLY DIAGNOSED AND RELAPSED/REFRACTORY CANCER INDICATIONS (KCP-8602-801)”
Principal Investigator
Mitul Gandhi, MD
1 Location
Trial ID
ERAS-007-04
Sponsor ID
HERKULES-4
A Phase 1b/2 Master Protocol of Agents Targeting the Mitogen-Activated Protein Kinase Pathway in Patients with Hematologic Malignancies (HERKULES-4).
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
